Envafolimab Chimeric Monoclonal Antibody
Envafolimabis a research-grade recombinant antibody targeting CD1. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
B7-H1, Programmed cell death 1 ligand 1, PDCD1 ligand 1, PDCD1L1, B7 homolog 1, PDCD1LG1, PDL1, hPD-L1, Programmed death ligand 1, B7H1, PD-L1, CD274
UniProt
Q9NZQ7
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Chimeric
Preservative
0.01M PBS, pH 7.4.
Isotype
(VH-CH2-CH3) 2
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
FBXO25 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV)
Recombinant Arabidopsis thaliana Serine carboxypeptidase-like 44 (SCPL44)
Recombinant Arabidopsis thaliana Serine carboxypeptidase-like 44 (SCPL44)
Recombinant Arabidopsis thaliana Serine carboxypeptidase-like 44 (SCPL44)